Skip to content

NEUROMETRIX, INC.: 10-Q filed 2021-10-21

What NEUROMETRIX, INC. reported in its quarterly report filed 2021-10-21 (fiscal Q3 2021): 38 published measures, 110 facts as tagged in accession 0001628280-21-020328.

This filing

Form
10-Q (quarterly report)
Filed
2021-10-21
Fiscal period
fiscal Q3 2021
Accession
0001628280-21-020328 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEUROMETRIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3026,293,669USD
At 2020-12-317,994,575USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-302,065,658USD
At 2020-12-312,746,800USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3024,228,011USD
At 2021-06-308,835,129USD
At 2021-03-315,261,052USD
At 2020-12-315,247,775USD
At 2020-09-305,371,772USD
At 2020-06-305,488,616USD
At 2020-03-312,514,118USD
At 2019-12-312,530,234USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3023,213,537USD
At 2020-12-315,226,213USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-687,089USD92
2021-01-01 to 2021-09-30-1,278,456USD273
2021-04-01 to 2021-06-30-531,584USD91
2021-01-01 to 2021-03-31-59,783USD90
2020-07-01 to 2020-09-30-257,113USD92
2020-01-01 to 2020-09-30-1,766,428USD274
2020-04-01 to 2020-06-30-851,944USD91
2020-01-01 to 2020-03-31-657,371USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-1,561,242USD273
2020-01-01 to 2020-09-30-2,348,068USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-30125,039USD273
2020-01-01 to 2020-09-300USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3019,673,605USD273
2020-01-01 to 2020-09-304,151,037USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-125,039USD273
2020-01-01 to 2020-09-300USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-198,160,256USD
At 2020-12-31-196,881,800USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,818,449shares92
2021-01-01 to 2021-09-304,597,580shares273
2020-07-01 to 2020-09-303,784,657shares92
2020-01-01 to 2020-09-302,755,903shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,818,449shares92
2021-01-01 to 2021-09-304,597,580shares273
2020-07-01 to 2020-09-303,784,657shares92
2020-01-01 to 2020-09-302,755,903shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.12USD/shares92
2021-01-01 to 2021-09-30-0.28USD/shares273
2020-07-01 to 2020-09-30-0.07USD/shares92
2020-01-01 to 2020-09-30-0.64USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.12USD/shares92
2021-01-01 to 2021-09-30-0.28USD/shares273
2020-07-01 to 2020-09-30-0.07USD/shares92
2020-01-01 to 2020-09-30-0.64USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-30204,939USD
At 2020-12-31183,494USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-30585,087USD273
2020-01-01 to 2020-09-30413,178USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-687,971USD92
2021-01-01 to 2021-09-30-1,280,129USD273
2020-07-01 to 2020-09-30-257,887USD92
2020-01-01 to 2020-09-30-1,768,751USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3025,560,390USD
At 2020-12-317,089,866USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-301,736,489USD
At 2020-12-312,285,390USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30316,969USD
At 2020-12-31142,316USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-30639,766USD
At 2020-12-31334,297USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,132,497USD92
2021-01-01 to 2021-09-305,959,116USD273
2020-07-01 to 2020-09-301,756,501USD92
2020-01-01 to 2020-09-305,684,104USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-30996,951USD
At 2020-12-311,051,282USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,444,526USD92
2021-01-01 to 2021-09-304,678,987USD273
2020-07-01 to 2020-09-301,498,614USD92
2020-01-01 to 2020-09-303,915,353USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-30619,833USD92
2021-01-01 to 2021-09-301,754,343USD273
2020-07-01 to 2020-09-30537,614USD92
2020-01-01 to 2020-09-301,652,890USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-30724,556USD92
2021-01-01 to 2021-09-301,599,358USD273
2020-07-01 to 2020-09-30652,671USD92
2020-01-01 to 2020-09-301,846,569USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-306,645,397shares
At 2020-12-313,793,739shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-09-3023,213,537USD
At 2020-12-315,226,213USD
At 2020-09-304,929,175USD
At 2019-12-313,126,206USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-30222,387,601USD
At 2020-12-31202,129,195USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30499,047USD
At 2020-12-31692,692USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-301,028,373USD
At 2020-12-31998,442USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-30710,136USD
At 2020-12-31478,074USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-1,278,456USD273
2020-01-01 to 2020-09-30-1,766,428USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30965,711USD92
2021-01-01 to 2021-09-303,254,210USD273
2020-07-01 to 2020-09-30762,903USD92
2020-01-01 to 2020-09-302,693,146USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-01-01 to 2021-09-30103,594USD273
2020-01-01 to 2020-09-3067,772USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30305,469USD273
2020-01-01 to 2020-09-30334,179USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-54,331USD273
2020-01-01 to 2020-09-30-113,421USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30174,653USD273
2020-01-01 to 2020-09-30-533,302USD274

Inspect the source

Entity
NEUROMETRIX, INC. / CIK 0001289850
Captured
2026-09-21T17:18:17.667Z
SEC response SHA-256
a8bcb6176e39f2b78532ab77047334a9ea544316148327f0e4d18bc7ac5fd7fa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001289850.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))